Cancer Incidence for Ridgewood, Glendale & Middle Village, Queens County, 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Males and Females | Males | Females | ||||||
---|---|---|---|---|---|---|---|---|---|
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 834.6 | 407.3 | 394.8-420.0 | 398.8 | 426.6 | 407.7-446.1 | 435.8 | 398.7 | 381.7-416.2 |
Oral cavity and pharynx | 22.6 | 11.0 | 9.1-13.3 | 15.4 | 16.3 | 12.8-20.5 | 7.2 | 6.6 | 4.6-9.3 |
Esophagus | 8.0 | 3.7 | 2.6-5.1 | 6.0 | 6.3 | 4.2-9.1 | 2.0 | 1.6 | 0.8-3.0 |
Stomach | 18.8 | 9.3 | 7.5-11.5 | 10.6 | 11.6 | 8.6-15.2 | 8.2 | 7.6 | 5.4-10.4 |
Colorectal | 78.0 | 37.4 | 33.7-41.3 | 39.6 | 41.9 | 36.1-48.3 | 38.4 | 33.9 | 29.2-39.3 |
Colon excluding rectum | 54.2 | 26.0 | 23.0-29.4 | 27.2 | 29.3 | 24.5-34.8 | 27.0 | 23.5 | 19.7-28.0 |
Rectum & rectosigmoid | 23.8 | 11.3 | 9.4-13.6 | 12.4 | 12.6 | 9.6-16.3 | 11.4 | 10.4 | 7.8-13.6 |
Liver / intrahepatic bile duct | 19.4 | 9.1 | 7.4-11.2 | 14.6 | 15.1 | 11.8-19.1 | 4.8 | 4.2 | 2.7-6.4 |
Pancreas | 25.8 | 12.3 | 10.2-14.6 | 9.4 | 10.1 | 7.4-13.6 | 16.4 | 13.7 | 10.9-17.1 |
Larynx | 5.4 | 2.6 | 1.7-3.8 | 4.2 | 4.3 | 2.6-6.7 | 1.2 | 1.1 | 0.4-2.4 |
Lung and bronchus | 90.8 | 43.1 | 39.2-47.4 | 45.0 | 48.9 | 42.6-55.8 | 45.8 | 39.2 | 34.2-44.7 |
Melanoma of the skin | 21.6 | 10.7 | 8.7-12.9 | 9.4 | 10.8 | 7.9-14.5 | 12.2 | 11.4 | 8.7-14.8 |
Female breast | 125.0 | 117.1 | 107.8-126.9 | ||||||
Cervix uteri | 9.2 | 9.1 | 6.6-12.3 | ||||||
Corpus uterus and NOS | 30.2 | 26.7 | 22.5-31.4 | ||||||
Ovary | 11.2 | 10.9 | 8.2-14.3 | ||||||
Prostate | 90.0 | 90.6 | 82.3-99.6 | ||||||
Testis | 4.2 | 4.9 | 3.0-7.6 | ||||||
Urinary bladder (incl. in situ) | 42.0 | 20.1 | 17.4-23.0 | 33.0 | 36.7 | 31.3-42.9 | 9.0 | 7.5 | 5.5-10.2 |
Kidney and renal pelvis | 31.8 | 15.8 | 13.4-18.5 | 20.2 | 21.7 | 17.6-26.4 | 11.6 | 10.6 | 8.0-13.9 |
Brain and other central nervous system | 10.6 | 5.5 | 4.1-7.2 | 5.0 | 5.3 | 3.4-7.9 | 5.6 | 5.6 | 3.7-8.3 |
Thyroid | 35.4 | 19.1 | 16.3-22.2 | 9.2 | 10.4 | 7.6-13.9 | 26.2 | 27.6 | 22.9-32.9 |
Hodgkin lymphoma | 4.4 | 2.5 | 1.5-3.8 | 2.6 | 3.0 | 1.6-5.2 | 1.8 | 2.0 | 0.9-3.9 |
Non-Hodgkin lymphomas | 38.0 | 18.9 | 16.2-21.8 | 22.4 | 24.3 | 19.9-29.4 | 15.6 | 14.0 | 11.0-17.6 |
Myeloma | 10.0 | 4.8 | 3.5-6.4 | 4.8 | 5.4 | 3.5-8.2 | 5.2 | 4.3 | 2.8-6.4 |
Leukemias | 26.0 | 13.1 | 10.9-15.6 | 15.4 | 16.9 | 13.3-21.3 | 10.6 | 9.8 | 7.2-12.9 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYC neighborhoods were defined in terms of Public Use Microdata Areas (PUMAs). PUMAs approximate NYC Community Districts (CDs).
- For more information about PUMAs, please refer to http://www1.nyc.gov/site/planning/data-maps/nyc-population/geographic-reference.page.